NasdaqGS - Nasdaq Real Time Price USD
Denali Therapeutics Inc. (DNLI)
14.38
+1.23
+(9.35%)
As of 3:36:46 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
COOK JENNIFER E Director | Sale | Jun 6, 2024 | 20,038 |
FLATLEY JAY T Director | Stock Award(Grant) | May 31, 2024 | 346,496 |
HO CAROLE Officer | Sale | Jan 7, 2025 | 383,892 |
KLEIN PETER S Director | Stock Award(Grant) | May 31, 2024 | 21,496 |
KROGNES STEVE E Director | Sale | Jan 7, 2025 | 807,554 |
SATO VICKI LEE Director | Sale | Jan 2, 2025 | 107,976 |
SCHENKEIN DAVID P Director | Conversion of Exercise of derivative security | Nov 11, 2024 | 66,684 |
SCHUTH ALEXANDER O Chief Operating Officer | Sale | Jan 7, 2025 | 768,057 |
TESSIER LAVIGNE MARC T Director | Stock Award(Grant) | May 31, 2024 | 2,117,410 |
WATTS RYAN J Chief Executive Officer | Sale | Jan 7, 2025 | 2,455,680 |
Related Tickers
ALEC Alector, Inc.
1.0850
+11.41%
RARE Ultragenyx Pharmaceutical Inc.
35.79
+1.10%
BPMC Blueprint Medicines Corporation
84.22
+0.04%
ORIC ORIC Pharmaceuticals, Inc.
5.15
+5.75%
PRTA Prothena Corporation plc
9.55
+2.63%
DYN Dyne Therapeutics, Inc.
9.96
+6.70%
PTCT PTC Therapeutics, Inc.
47.99
-0.42%
ACAD ACADIA Pharmaceuticals Inc.
14.33
-0.35%
AKRO Akero Therapeutics, Inc.
38.82
+3.05%
EWTX Edgewise Therapeutics, Inc.
13.65
+2.59%